|
PSMD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.715360E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.198150E-03 |
| Normal-vs-Stage2 |
7.346000E-02 |
| Normal-vs-Stage3 |
6.633200E-01 |
| Normal-vs-Stage4 |
5.934200E-01 |
| Stage1-vs-Stage2 |
9.644800E-01 |
| Stage1-vs-Stage3 |
1.659650E-01 |
| Stage1-vs-Stage4 |
5.626800E-01 |
| Stage2-vs-Stage3 |
2.888200E-01 |
| Stage2-vs-Stage4 |
5.939200E-01 |
| Stage3-vs-Stage4 |
7.848800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.026600E-04 |
| Normal-vs-AfricanAmerican |
1.048960E-01 |
| Normal-vs-Asian |
6.897000E-01 |
| Caucasian-vs-AfricanAmerican |
4.180600E-01 |
| Caucasian-vs-Asian |
1.423150E-01 |
| AfricanAmerican-vs-Asian |
3.100800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54030000002015E-06 |
| Normal-vs-Female |
3.136400E-01 |
| Male-vs-Female |
2.3380999999989E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.829600E-02 |
| Normal-vs-Extreme_Weight |
3.85690000004324E-06 |
| Normal-vs-Obese |
4.465700E-02 |
| Normal-vs-Extreme_Obese |
7.807700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.351800E-01 |
| Normal_Weight-vs-Obese |
8.579200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.823800E-01 |
| Extreme_Weight-vs-Obese |
6.917700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.920400E-01 |
| Obese-vs-Extreme_Obese |
3.358200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.405200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.567500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.010740E-04 |
| Normal-vs-Age(81-100Yrs) |
1.219440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.326400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.423100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.579600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.229600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.313000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.205510E-04 |
| Normal-VS-Type2 PRCC |
4.071700E-02 |
| Normal-VS-KIRP CIMP |
1.328590E-01 |
| Normal-VS-Unclassified PRCC |
6.570400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.304200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.840400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.893500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.724200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.800400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.796300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402190E-03 |
| Normal-vs-N1 |
6.129800E-01 |
| Normal-vs-N2 |
4.770800E-01 |
| N0-vs-N1 |
1.347880E-02 |
| N0-vs-N2 |
4.201700E-02 |
| N1-vs-N2 |
5.306400E-01 |
|
|
